| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 153,608 | 143,726 | 117,300 | 173,325 | | Cost of Revenue | 128,572 | 120,589 | 103,522 | 151,423 | | | Gross Profit | 25,036 | 23,137 | 13,778 | 21,902 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 17,042 | 17,607 | 16,078 | 24,673 | | Non Recurring |
-
|
-
|
-
| 135,631 | | Others | 7,645 | 7,450 | 7,456 | 8,139 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (56,240) | (1,920) | (9,756) | (146,541) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,703) | 3,248 | 4,848 | 470 | | Earnings Before Interest And Taxes | (75,822) | 1,328 | (4,908) | (146,071) | | Interest Expense | (13,330) | 6,556 | 6,774 | 7,049 | | Income Before Tax | (62,492) | (5,228) | (11,682) | (153,120) | | Income Tax Expense | (1,194) | (431) | (637) | (19,947) | | Minority Interest | 3,238 | 2,394 |
-
| 980 | | | | Net Income From Continuing Ops | (63,692) | (2,403) | (11,045) | (132,193) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (58,060) | (2,403) | (11,045) | (132,193) | | Preferred Stock And Other Adjustments |
-
| (1,591) | 1,591 |
-
| | | Net Income Applicable To Common Shares | ($58,060) | ($3,994) | ($9,454) | ($132,193) |
|
0.02% Nasdaq 
Income Statement
